American Journal of Hematology: Vol 96, No 9

I consent to Wiley Online Library’s Terms of Use and processing of my personal data as disclosed in Wiley’s Privacy Policy.I consent to my personal information being transferred outside of the People’s Republic of China as laid out in Wiley’s Privacy Policy.*(Optional) I consent to special offers, newsletter & promotions from Wiley. See Privacy Policy for more details.

Tools

Submit an article

Journal Metrics

Subscribe to this journal

Related Title

LATEST ISSUE
Volume 6, Issue 4
August 2025

Posts by AjHematology

American Journal of Hematology

Journal list menu

Tools

Follow journal

American Journal of Hematology: Volume 96, Issue 9

Download PDFs

ISSUE INFORMATIONx

Issue Information

EDITORIAL

Food and science: Lessons learned from a great chef

RESEARCH ARTICLES

Comprehensive phenotyping of erythropoiesis in human bone marrow: Evaluation of normal and ineffective erythropoiesis

Genetic screening of children with marrow failure. The role of primary Immunodeficiencies

Adverse events reported to the U.S. Food and Drug Administration Adverse Event Reporting System for tisagenlecleucel

Chimeric antigen receptor T-cells safety: A pharmacovigilance and meta-analysis study

Health-related quality of life with fixed-duration venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: Results from the randomized, phase 3 CLL14 trial

Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk

Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trials

Correction(s) for this article

Correction to “Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trials”

Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantation

Risk factors for CKD stage II onset in a prospective cohort of homozygous sickle cell adults

Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results

Cardiovascular phenotypes predict clinical outcomes in sickle cell disease: An echocardiography-based cluster analysis

CLINICAL PEARLS IN BLOOD DISEASES

MORPHOLOGY UPDATE

Unexpected Leishmania in a bone marrow aspirate

IMAGES IN HEMATOLOGY

Disseminated coccidioidomycosis in bone marrow

DIAGNOSTIC IMAGING IN HEMATOLOGY

Thrombocytopenia and splanchnic thrombosis after Ad26.COV2.S vaccination successfully treated with transjugular intrahepatic portosystemic shunting and thrombectomy

CORRESPONDENCES

Clinical, biological, and molecular genetic features of Richter syndrome and prognostic significance: A study of the French Innovative Leukemia Organization

Lactate dehydrogenase to carboxyhemoglobin ratio as a biomarker of heme release to heme processing is associated with higher tricuspid regurgitant jet velocity and early death in sickle cell disease

Multiple thrombosis in a patient with Gardos channelopathy and a new KCNN4 mutation

Comparison of neutralizing antibody responses against SARS-CoV-2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier?

Incidence of cancer among U.S. combat casualties: a DoD Trauma Registry study

Clinical features and survival outcomes in patients with chronic myelomonocytic leukemia arising in the context of germline predisposition syndromes

Clonal hematopoiesis in patients with Covid-19 is stable and not linked to an aggravated clinical course

Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996

Interpretation of retrospective data evaluating high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma; caution required

Prophylactic high-dose methotrexate in diffuse large B cell lymphoma, authors' response

Persistent bone marrow minimal residual disease as a “high-risk” disease feature in multiple myeloma

SARS-CoV-2 vaccination induces breakthrough hemolysis in paroxysmal nocturnal hemoglobinuria on complement inhibitor

Vaccine-induced thrombotic thrombocytopenia following Ad26.COV2.S vaccine in a man presenting as acute venous thromboembolism

Post-transplantation donor-derived Sezary syndrome in a patient with A91V PRF1 variant hemophagocytic lymphohistiocytosis

Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (FILO)

Cerebral venous thrombosis post BNT162b2 mRNA SARS-CoV-2 vaccination: A black swan event

Sign up for email alerts

Tools

More from this journal

Related Title